Bangalore, April 11th, 2025: HCG Cancer Centre Bangalore announced the signing of a Memorandum of Understanding (MoU) with Samraksha – Thalassemia Day Care Centre. The agreement focuses on providing subsidized Bone Marrow Transplants (BMT), primarily benefiting economically disadvantaged pediatric patients battling thalassemia. The partnership will be further strengthened by the support of the Coal India Foundation, which will provide crucial financial assistance to ensure that deserving children under the age of 12 receive free treatment.
This collaboration focuses on providing a comprehensive solution for thalassemia patients, combining clinical expertise with financial support. Under the MoU, Samraksha and Rashtrotthana Hospital will identify eligible patients, providing them with holistic support throughout their treatment journey, while HCG Cancer Centre will offer the necessary infrastructure and clinical expertise to perform Bone Marrow Transplants. Additionally, the partnership is further strengthened by the Coal India Foundation, which will provide financial assistance for deserving patients under the age of 12, ensuring they receive free treatment and have access to life-changing care at HCG Cance Centre Bangalore. This combined effort aims to improve the long-term outcomes for thalassemia patients and offer them the possibility of a cure, reducing their dependency on regular blood transfusions.
Ms. Manisha Kumar, Chief Operating Officer Karnataka, Healthcare Global Enterprises Limited said “This partnership with Samraksha marks a pivotal moment in advancing the treatment of thalassemia. By combining HCG’s clinical expertise with Samraksha’s dedicated patient support, we are offering not just a potential cure but also significantly improving long-term health outcomes for thalassemia patients. With our commitment to providing subsidized care, we are ensuring that life-changing treatments are accessible to families in need, giving them the opportunity for a healthier, transfusion-free future. Together, we are changing the course of thalassemia care and bringing renewed hope for a better quality of life.”
Shri K S Narayana, Managing Trustee of Rashtrotthana Hospital said “This partnership is a significant milestone in providing hope and a cure for thalassemia patients. By combining the expertise of HCG Cancer Centre and Samraksha with the support of Coal India Foundation, we are offering a brighter future to children and families who have long struggled with this debilitating condition. Together, we are committed to making life-saving treatments more accessible and transforming the lives of those in need.”
This collaboration between HCG Cancer Centre and Samraksha is a vital step toward improving the lives of children and families affected by thalassemia. By combining clinical expertise, financial support, and a shared commitment to accessible healthcare, this partnership aims to create lasting, positive change in the lives of those who need it the most. As this initiative unfolds, it will provide countless families with new hope for a healthier future, helping to reduce the burden of thalassemia and pave the way for more widespread access to curative treatments across India. HCG Cancer Centre remains dedicated to its mission of transforming healthcare and ensuring that life-saving treatments are within reach for all.